Division of Vascular Surgery and Endovascular Therapy, Johns Hopkins Hospital, Baltimore, MD.
Department of Surgery, Johns Hopkins University School of Medicine Baltimore MD, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Ann Vasc Surg. 2022 Mar;80:70-77. doi: 10.1016/j.avsg.2021.09.024. Epub 2021 Nov 12.
Intravascular ultrasound (IVUS) may be a useful adjunct to lower extremity peripheral vascular interventions (PVI) in certain clinical scenarios. We aimed to identify patient- and physician-level characteristics associated with the use of IVUS during first-time femoropopliteal PVI.
We included all Medicare beneficiaries undergoing elective femoropopliteal PVI for claudication or chronic limb-threatening ischemia between 01/01/2019 and 12/31/2019. We excluded patients with prior open or endovascular femoropopliteal intervention and all physicians performing ≤10 PVI during the study period. We calculated the proportion of patients who had IVUS performed as part of their index PVI for each physician. Hierarchical logistic regression was used to evaluate patient- and physician-level factors associated with use of IVUS.
We identified 58,552 patients who underwent index femoropopliteal PVI, of whom 11,394 (19%) received IVUS. A total of 1,628 physicians performed >10 procedures during the study period, with IVUS utilization ranging from 0-100%. After hierarchical regression, claudication (versus chronic limb-threatening ischemia: OR 1.23, 95% CI 1.11-1.36), stenting (versus angioplasty alone: OR 1.57, 1.33-1.86) and atherectomy (versus angioplasty alone: OR 2.09, 1.83-2.39) were associated with higher odds of IVUS utilization. Higher-volume providers (tertile 3 vs. tertile 1: OR 3.78, 2.43-5.90) and those with high rates of service provided in an office-based laboratory (tertile 3 vs. tertile 1: OR 10.72, 6.78-19.93) were more likely to utilize IVUS. Radiologists (OR 11.23, 5.96-21.17) and cardiologists (OR 1.97, 1.32-2.93) used IVUS more frequently than vascular surgeons.
Wide variability exists in the use of IVUS for first-time femoropopliteal PVI. The association of IVUS with claudication, atherectomy, and office-based laboratories raises concern about its potential overuse by some physicians.
在某些临床情况下,血管内超声(IVUS)可能是下肢外周血管介入(PVI)的有用辅助手段。我们旨在确定与首次股腘 PVI 期间使用 IVUS 相关的患者和医生特征。
我们纳入了所有在 2019 年 1 月 1 日至 12 月 31 日期间因跛行或慢性肢体威胁性缺血而行择期股腘 PVI 的 Medicare 受益人的数据。我们排除了既往行股腘开放或血管内干预以及在研究期间行 PVI 手术≤10 例的患者。我们计算了每位医生行索引 PVI 时行 IVUS 的患者比例。分层逻辑回归用于评估与 IVUS 使用相关的患者和医生特征。
我们确定了 58552 名接受索引股腘 PVI 的患者,其中 11394 名(19%)接受了 IVUS。在研究期间,共有 1628 名医生进行了>10 次手术,IVUS 使用率为 0-100%。经过分层回归,跛行(与慢性肢体威胁性缺血相比:比值比 1.23,95%置信区间 1.11-1.36)、支架置入术(与单纯血管成形术相比:比值比 1.57,1.33-1.86)和旋切术(与单纯血管成形术相比:比值比 2.09,1.83-2.39)与 IVUS 使用率较高相关。高容量提供者(三分位 3 比三分位 1:比值比 3.78,2.43-5.90)和在办公室实验室提供高比例服务的提供者(三分位 3 比三分位 1:比值比 10.72,6.78-19.93)更有可能使用 IVUS。放射科医生(比值比 11.23,5.96-21.17)和心脏病专家(比值比 1.97,1.32-2.93)比血管外科医生更频繁地使用 IVUS。
首次股腘 PVI 中 IVUS 的使用存在广泛差异。IVUS 与跛行、旋切术和基于办公室的实验室的关联引起了人们对一些医生过度使用的担忧。